UBS Adjusts 2019 Dividend Payout Proposal On FINMA's Request - Quick Facts

By RTTNews Staff Writer ✉ | Published: 4/9/2020 3:09 AM ET

UBS (UBS) said, following a request from FINMA, the Board asks shareholders to approve a dividend distribution of $0.365 per share to be paid on 7 May 2020 and a special dividend reserve of $0.365 per share. The Board intends to propose the distribution of the additional $0.365 per share at an extraordinary general meeting, to be convened on 19 November 2020.

UBS currently expects to report first quarter net profit of around $1.5 billion. The company will publish its first quarter results on 28 April.

For comments and feedback contact: editorial@rttnews.com

Business News

Biotech Stocks PDUFA COVID 19 Vaccines peanut allergy Trelegy Ellipta Pain drug exertional heatstroke allergic conjunctivitis

Biotech Stocks Facing FDA Decision In August 2020

New Drugs Approved In June

Coronavirus Vaccines In Human Trials COVID19 Antibodies Spike Protein US Operation Warp Speed

Tracking Coronavirus Vaccines In Human Trials

Editors Pick

Facebook Releases Instagram Reels

Facebook has unveiled Instagram Reels as its answer to the popular Chinese-owned video app TikTok. The social media giant said in a blog post that Instagram Reels is a new way to create short, entertaining videos on Facebook's photo-sharing app Instagram. Facebook reportedly shut down its TikTok clone Lasso in July, ahead of the launch of Instagram Reels.

WD-40 Company Recalls About 130k Units Of X-14 Mildew Stain Remover

WD-40 Company recalled about 130,000 units of X-14 Mildew Stain Remover for potential risk of skin irritation, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said pressure can build up inside the bottle and cause it to fall over and leak, posing a risk of skin irritation.

Bristol-Myers Slips To Loss In Q2, But Results Top Estimates

Biopharmaceutical company Bristol-Myers Squibb Co. on Thursday reported a loss for the second quarter, compared to a profit last year, hurt primarily by hefty amortization expenses. However, adjusted earnings per share and quarterly revenues topped analysts' expectations. Looking ahead, the company raised its adjusted earnings and revenue outlook for the full-year 2020.